TRINITY BIOTEC.ADR NEW A
TRINITY BIOTEC.ADR NEW A
Certificado de depósito · US8964385046 · TRIB · A404JF (XNAS)
Resumen
0,57 EUR
2,88 % 0,02 EUR
Frankfurt (XNAS) · Precios actuales y gráficos en MoneyPeak
06.06.2025 19:43

Cotizaciones actuales de TRINITY BIOTEC.ADR NEW A

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
TRIB
USD
06.06.2025 19:43
0,65 USD
0,64 USD
+2,23 %

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
-0,45 % -1,63 % -14,06 % -11,38 % -33,83 % -70,65 % -92,06 %

Perfil de la empresa para TRINITY BIOTEC.ADR NEW A Certificado de depósito

Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

Datos de la empresa

Nombre TRINITY BIOTEC.ADR NEW A
Empresa Trinity Biotech plc
Símbolo TRIB
Sitio web https://www.trinitybiotech.com
Mercado principal XNAS Frankfurt
WKN A404JF
ISIN US8964385046
Tipo de valor Certificado de depósito
Sector Healthcare
Industria Medical - Diagnostics & Research
CEO Mr. John Gillard
País Irlanda
Moneda EUR
Empleados 0,4 T
Dirección IDA Business Park, A98 H5C8 Bray
Fecha de OPV 1992-10-21

Cambios de identificador

Fecha De A
30.06.2005 TRIBD TRIB

Símbolos de cotización

Nombre Símbolo
Frankfurt TRB.F
NASDAQ TRIB

Otras acciones

Los inversores que tienen TRINITY BIOTEC.ADR NEW A también tienen las siguientes acciones en su cartera:
CENTURION MINERALS LTD
CENTURION MINERALS LTD Acción
HCO        ZSXL2 13/23
HCO ZSXL2 13/23 Bono
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025